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Socioeconomic Status and Breast Cancer Survival 
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C.T.M. Schrijvers, J.W.W.Coebergh, L.H. van der Heijden 
and J.P. Mackenbach 
Socioeconomic differences in breast cancer survival in the southeastern Netherlands between 1980 and 1989 were 
studied (n = 3928), as was the impact of prognostic factors (stage at diagnosis, morphology, and treatment) on 
such differences. An area-based measure of socioeconomic status (SES) in five groups, based on the postcode of 
residence at the time of diagnosis, was used. In univariate analyses the relative survival rate was used to correct 
for causes of death other than breast cancer. The measure of outcome in multivariate analyses was the hazard 
ratio. The results of both univariate and multivariate analyses suggested a small survival advantage for the higher 
SES groups. In a model with follow-up period, SES and age, the hazard ratios with 95% confidence intervals (CI) 
for SES groups from high to low were: 1.00,1.06 (O&l-1.33), 1.04 (O&-1.26), 1.15 (0.961.38), 1.18 (0.99-1.42). 
After a correction for stage at diagnosis, differences in survival were reduced substantially. Morphology and 
treatment were not important explanatory factors of the SES survival association. We conclude that small 
socioeconomic differences in breast cancer survival exist in The Netherlands and that stage at diagnosis is the 
most important determinant of such differences. 
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INTRODUCTION 
BREAST CANCER is the most common cancer among females in 
The Netherlands [I] as in many developed countries. Dutch 
women experience one of the highest incidence rates in the world 
[2]. The 5 year relative survival rate of breast cancer patients in 
the period 1975-1985 in the southeastern Netherlands was 69% 
[31. 
Socioeconomic differences in breast cancer survival have been 
reported in studies from the United States [4], Finland [5], 
Sweden [6], Australia [7], Scotland [8] and England and Wales 
[9]. Except for one [9], these studies on patients diagnosed in 
the 1960s or later, showed that breast cancer patients of low 
socioeconomic status (SES) have a higher chance of dying from 
their disease than breast cancer patients of high SES. 
This paper is the first report on the impact of SES on 
breast cancer survival iu The Netherlands, a country that is 
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characterised by a relative lack of geographical and financial 
barriers to primary and specialised care. A description of the 
association between an area-based measure of SES and breast 
cancer survival in the 1980s is given and possible explanations of 
this association were studied. With respect o the latter, it was 
tested whether the difference in survival from breast cancer in 
different SES groups can be explained by the distribution of a 
number of prognostic factors: stage at diagnosis, morphology 
and treatment. 
Patients 
PATENTS AND METHODS 
Data for this study were derived from the population-based 
Eiudhoven Cancer Registry, The Netherlands, which serves an 
area of about one million inhabitants (about 7% of the Dutch 
population) iu the southeastern part of The Netherlands [2]. 
The registry identifies newly diagnosed cases of cancer through 
routine reports from departments of pathology and radio- 
therapy, through m-patient records from all eight community 
hospitals in the region, as well as through data from specialised 
departments and hospitals outside of the region [2, lo]. In this 
region, the distance to a hospital is always less than 30 km and 
that to a radiotherapy department is always less than 50 km. All 
hospitals use the same criteria for the clinical assessment and 
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treatment of breast cancer patients as they adhere to the guide- to one of the five socioeconomic groups of the proxy measure 
lines developed by the regional Breast Cancer Study Group [ 111. (using the same procedure as with the marketing agency data). 
The records of all women diagnosed with an invasive tumour 
of the breast between 1980 and 1989 (n = 3959) were checked. 
Patients with an unknown basis of diagnosis (n = 3), diagnosis 
based on autopsy (n = 2), or unknown address at diagnosis 
(n = 21) were excluded from the basic material. The remaining 
3933 patients were followed up until 1 July 1991, through the 
virtually complete municipal registries in the area, to determine 
their vital status. This was unknown for 5 patients, thus finally 
3928 patients were included in the study. 
Both patients with (96%) and those without (4%) a histologi- 
cally confirmed breast tumour were included in the study, as 
there was no systematic difference in the proportion of patients 
with a histologically co&rned breast umour according to SES 
group. 
For each postcode we thus had two scores: (1) a score from 1 
to 5 based on data from the original classification of the marketing 
agency; and (2) a score from 1 to 5 based on data from 
respondents to the survey. The Pearson correlation coefficient 
between the two variables was 0.5 1, which is rather high for this 
type of comparison. We concluded from this exercise that 
validity at the postcode level was satisfactory, given that the 
assignment of postcodes to one of 45 categories by the marketing 
agency was based on a large number of socioeconomic and socio- 
demographic variables, of which education was only one. 
Prognostic factors 
SES 
Because no data on the SES of individual patients were directly 
available from the cancer registry, a proxy measure of SES was 
used, based on the place of residence at time of diagnosis of each 
patient. Data to develop the proxy measure were obtained 
from a commercial marketing agency, which had assigned each 
postcode (average of 16 hous’eholds) in our study area to one of 
45 socioeconomic ategories, using a wide range of socioeco- 
nomic and sociodemographic: survey data at the postcode level. 
The central variable in our a.nalysis was education; the agency 
provided us with information on the percentage of main bread- 
winners in three educational groups (low, medium, high) for 
each of the 45 socioeconomic categories. These three educational 
groups encompassed several types of schooling, and we assigned 
an average number of years of education to each of them: 7.5 
years to the lowest educational category (range of education 
between 6 and 9 years), 10 years to the medium educational 
category (years of education either 10 or 11) and 15 years to 
the highest educational category (range of years of education 
between 12 and 18). 
We studied the impact of a number of potential confounders 
and intermediary variables, which were treated as categorical in 
the analysis. As potential confounders of the SES survival 
association we studied: age at diagnosis (three categories: younger 
than 50,50 to 64, and 65 years or older), period of diagmsis (two 
categories: 1980-1984 and 1985-1989) and degree of urbantiatim 
of the place of residence at diagnosis (three categories: (1) 
smallest municipalities; (2) intermediate; (3) largest 
municipalities). The following potential intermediary variables 
in the association between SES and survival were studied: stage 
at diagnosis (four categories: localised (only local involvement of 
a tumour), regional (tumour growth confined to the breast and 
regional ymph nodes), distant (presence of metastases to other 
organs), and unknown), morphology (three categories: ductal 
carcinoma, lobular carcinoma or other [ 131) and treatment (five 
categories: (1) surgery only; (2) surgery and radiotherapy; (3) 
surgery and endocrine therapy; (4) surgery and chemotherapy; 
and (5) no surgery). 
Univariate analysis 
The information on the percentage of main breadwinners in 
each of these three educational groups was then used to calculate 
a summary measure of the avlerage number of years of education 
for each of the 45 socioeconomic ategories. The 45 socioeco- 
nomic categories were then ranked from low (7.8 years) to high 
(13.8 years) according to their summary score on education, 
and five socioeconomic ategories were constructed, based on 
quintiles of the underlying population. So the lowest SES 
category [l] contained approximately 20% of the population 
living in areas with the lowest educational level and the highest 
SES category [5] contained approximately 20% of the population 
living in areas with the highest education level. Finally, each 
woman was assigned to one of the five categories of SES through 
her postcode of residence at the time of diagnosis. 
The survival time of patients was calculated as the number of 
days between the date of diagnosis and either the date of death 
or the end of follow-up (1 July 1991), whichever occurred first. 
As no information on the exact cause of death was available, the 
Relative Survival Rate (RSR) was used to correct for deaths due 
to causes other than breast cancer. The RSR [ 141 is the ratio of 
the observed survival rate for a group of cancer patients to the 
expected survival rate in a group similar to the patient group 
with respect o age, sex, and calendar period of observation. In 
this study, the expected survival rate was based on life tables of 
the population of the registration area of the Eindhoven Cancer 
Registry, which were obtained from The Netherlands Central 
Bureau of Statistics. These life tables each applied to a 2 year 
calendar period and were age- and sex-specific. RSRs and 95% 
confidence intervals (CI) were calculated with the computer 
programme package for cancer survival studies from the Finnish 
Cancer Registry [ 151. 
We validated the proxy measure of SES in a subsample of 
respondents to a postal survey, which had been carried out in a 
part of the registration area of the Eindhoven cancer registry 
[ 121. The subsample consisted of respondents living in postcode 
areas for which at least six respondents were found in the survey, 
as the postcode area was the unit of measurement in this analysis. 
Each postcode could be assigned to one of the five socioeconomic 
categories of the proxy measure. For respondents to the survey, 
data on educational evel were known and for each of the 
381 postcodes, we calculated the average number of years of 
education with the survey data and then assigned each postcode 
Multivariate analysis 
The multivariate analyses were conducted with a proportional 
hazards regression model which was adapted to the RSR [16] 
using GLIM (generalised linear interactive modelling) [ 171. The 
measure of effect in the multivariate analyses was the hazard 
ratio, which expresses the probability of death from breast 
cancer for a specific category of patients relative to a reference 
category (with a hazard ratio of unity). 
The entire period of follow-up was divided into two periods 
of 6 years: l-6 and 7-12. Because the probability of death from 
breast cancer was not equal for these two periods, it was 
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necessary to correct for this difference in hazards by including 
this variable in the model. At every step in the multivariate 
analysis an extra variable was added to a model which contained 
follow-up period and SES. First, possible confounders were 
added to the model and then possible intermediary variables. 
For a variable to be included in the final model, it had to cause a 
change in hazard ratios of the SES variable after addition to the 
model. Furthermore, the reduction in deviance due to a variable, 
with a corresponding difference in degrees of freedom, using 
the &i-square distribution, had to be statistically significant 
(P < 0.05). 
At each step in the analysis, a test for trend with the SES 
variable was also conducted by including SES as a continuous 
variable in the model. The reduction in deviance due to the 
continuous SES variable was then evaluated, using the chi- 
square distribution with one degree of freedom. 
RESULTS 
Table 1 contains the 5 and 10 year RSR for the five SES 
categories, uncorrected for other factors. Both the 5 and 10 year 
RSR appeared to be higher for the higher SES categories, 
although a clear gradient was not apparent and 95% CIs over- 
lapped. 
The distribution of age (P < 0.001) and degree of urbanis- 
ation (P < 0.001) differed statistically significantly per SES 
category (Table 2), while for the other variables this was not 
the case: period of diagnosis (P = 0.61), stage (P = O.OS), 
morphology (P = 0.11) and treatment (P = 0.93). For stage 
however, we saw that the percentage of patients diagnosed at a 
distant stage was higher in the lower SES categories. 
Table 3 contains the results of the multivariate analyses, 
showing the hazard ratios for the five SES categories for the 
different models, with the highest SES category as a reference 
category. Period of diagnosis and degree of urbanisation were 
added to a model with follow-up period and SES, but appeared 
not to confound the SES survival association. These are, there- 
fore, not presented in Table 3. In model 1 which included 
follow-up period and SES, the gradient in hazard ratios was clear 
and the lower SES categories howed higher hazard ratios. The 
P-value for the test for trend was 0.037. When age was included 
in the model (model 2) the hazard ratios for SES were reduced 
substantially, while the reduction in deviance was also statisti- 
cally significant. CIs around hazard ratios for the five SES 
categories overlapped, but a gradient was apparent with higher 
hazard ratios for the lower SES categories (test for trend, 
P = 0.073). After a correction for stage (model 3), differences in 
hazard ratios became much smaller and the gradient disappeared 
(P = 0.841). The reduction in deviance due to stage was also 
Table 1. Five and 10 year relative survival rate (%) according 
to socioeconomic status in breast cancer patients 198&1989, in 
southeastern Netherlands 
SES n (%) 5 year RSR 
1 (low) 902 (23.0) 73 (70-7q* 
2 987 (25.1) 72 (68-76) 
3 814 (20.7) 75 (71-79) 
4 430 (10.9) 74 (69-79) 
S (high) 795 (20.2) 77 (73-81) 
Total 3928 (100) 74 (72-76) 
*95% confidence interval in parentheses. 
10 year RSR 
57 (N-64)’ 
61 (55-67) 
65 (5172) 
64 (55-73) 
64 (B-70) 
62 (B-65) 
statistically sign&ant. Morphology (model 4) and treatment 
(model 5) changed hazard ratios only moderately but because 
the reduction in deviance due to these variables was statistically 
significant, they were retained in the final model. 
DISCUSSION 
Our results suggest hat socioeconomic differences in breast 
cancer survival exist in The Netherlands: after a correction for 
age, mortality due to breast cancer was 18% higher in the lowest 
SES category than in the highest SES category. Although CIs 
for the different SES categories overlapped, agradient in hazard 
ratios for different SES categories was apparent (P = 0.073). 
Socioeconomic differences in breast cancer survival could mainly 
be ascribed to differences in the stage-distribution between the 
SES categories, particularly to differences in the percentage of 
patients diagnosed with a metastasis, which was 8.6 for the 
lowest and 5.4 for the highest SES category. 
Before we continue with the interpretation of our findings, 
some methodological issues concerning the proxy measure of 
SES have to be considered. The measure of SES is ecological 
and based on the average number of years of education per 
postcode of residence, and, therefore, misclassification, resulting 
in an underestimation of the SES survival gradient, cannot be 
ruled out. The results from our validation study showed, 
however, that our measure of SES is a very reasonable indicator 
at the postcode level, which is the basic unit of measurement in
our analyses. The postcode of residence at the time of diagnosis 
was used to assign each patient o a socioeconomic category. The 
area of residence of a patient and, therefore, her SES score 
could have changed during the follow-up period. It seems very 
unlikely, however, that migration after the diagnosis of cancer 
was differential according to SES. 
Due to the use of one single life table to correct for causes of 
death other than breast cancer, we may have overestimated the 
gradient in survival by SES. Expected survival is overestimated 
for lower SES groups and, therefore, relative survival is under- 
estimated and the hazard ratio is overestimated. For higher 
SES groups, expected survival might be underestimated, and, 
therefore, the relative survival is overestimated and the hazard 
ratio might be underestimated for these groups. In a Finnish 
study [5], it was shown that this overestimation of the SES 
survival gradient is probably not very large. In this study, the 
socioeconomic gradient in both corrected survival (censoring of 
cases dying from causes other than breast cancer) and relative 
survival were calculated. The ratio of survival rates of the highest 
and lowest social class was somewhat higher when the RSR was 
used (1.12) as compared to the corrected survival rate (CSR) 
(1.10). This overestimation of the SES survival gradient is 
probably smaller in The Netherlands than in Finland, as socio- 
economic variation in general mortality is smaller in The Nether- 
lands than in Finland [ 181. 
A direct comparison of our findings with those from other 
studies [4-91 is rather difficult, as studies differ in design and 
data analysis. In most studies a better survival for higher SES 
groups was found. However, in a study on English breast cancer 
patients diagnosed between 1971 and 1981, a non-significant 
better survival was found for council tenants (low SES) than for 
owner-occupiers (high SES) [9]. In a study on Swedish breast 
cancer patients (period of diagnosis 1961-1979) the RSR of 
white collar workers was approximately 7% higher than that of 
blue collar workers, without a correction for other prognostic 
factors [6]. The relative risk of case fatality in low SES women 
from South Australia (1977-1982), was 1.35 (95% CI 
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Table 2. Distribution of powble confmnders and intermediary factors according to socioeconomic status in breast cancer patients 
1980-1989, in southeastem Netherlands 
SES = 1 
low* 
lOO%I 
SES = 2 SES = 3 SES = 4 
100% 100% 100% 
SES = 5 
high* 
100% 
Total 
100% 
xz test 
G49 
50-64 
265 
Period of diagnosis 
80-84 
85-89 
Degree of 
urbanisation 
1 
2 
3 
Stage 
Local 
Regional 
Distant 
unknown 
Morphology 
Ductal 
Lobular 
Other 
Treatment 
SU 
Su + Ra 
Su + En 
Su+Ch 
No Su 
24.7 30.2 25.1 29.8 34.1 28.6 
38.5 33.8 34.6 33.0 34.2 35.1 
36.8 36.0 40.3 37.2 31.7 36.3 
P < 0.001 
P = 0.61 
P < 0.001 
P = 0.08 
P = 0.11 
P = 0.93 
46.2 43.0 43.2 42.8 44.2 44.0 
53.8 57.0 56.8 57.2 55.8 56.0 
8.3 15.9 10.3 3.5 2.9 9.0 
38.5 57.3 40.4 33.7 52.6 46.0 
53.2 26.8 49.3 62.8 44.5 45.0 
48.4 46.9 46.7 49.3 49.6 48.0 
31.8 33.6 33.2 31.9 35.8 33.4 
8.6 6.8 6.3 6.5 5.4 6.8 
11.2 12.7 13.8 12.3 9.2 11.8 
79.0 78.1 82.2 77.4 82.4 80.0 
12.6 13.5 9.3 13.1 10.7 11.8 
8.4 8.4 8.5 9.5 6.9 8.2 
22.3 22.0 19.9 22.1 20.1 21.3 
56.4 55.1 55.4 52.1 56.2 55.4 
6.5 7.9 8.6 8.4 7.4 7.7 
6.8 7.1 7.9 7.9 7.9 7.4 
8.0 7.9 8.2 9.5 8.4 8.3 
SES, socioeconomic status; Su, s#urgery; Ra, radiotherapy; En, endocrine therapy; Ch, chemotherapy. 
Table 3. Hazard ratios accom!ing to socioeconomic status in breast cancer patients 1980-1989 in southeastem Netherlands: result offtting 
models with several confnmders and intermediary factors 
Model SES = 1 
low* 
SES = 2 SES = 3 SES = 4 SES = 5 
high* 
Test for trend 
l.FU+SES 1.24 
(1.03-1.49)t 
2. + Age 1.18 
(0.9s1.42) 
3. + Stage 1.03 
(0.87-1.22) 
4.+MO 1.03 
(0.87-1.22) 
5.+TR 1.03 
(0.87-1.22) 
1.17 
(0.97-1.41) 
1.15 
(0.96-1.38) 
(Ok?26) 
(0.&?26) 
1.04 
(0.88-1.23) 
1.09 
(0.90-1.33) 
(0.8lLy.26) 
(0.81;-?.25) 
1.04 
(0.87-1.24) 
1.03 
(0.87-1.23) 
(0.8’;?38) 
(0.8??.33) 
1.09 
(0.88-1.34) 
1.07 
(0.87-1.33) 
1.04 
(0.84-1.29) 
1.00 P = 0.037 
1.00 P = 0.073 
1.00 P = 0.841 
1.00 P = 0.802 
1.00 P = 0.792 
*Reference category; t95% confidence intervals in parentheses; FU, follow-up period, SES, socioeconomic status; MO, morphology, TR, treatment 
1281. 
(1.04-1.74)) after correction. for age and histology [7]. 5 year higher risk of dying for the lowest SES group was found [4, 51, 
survival was 66% in the highest SES group compared with 55% which is not the case in our study. For Finnish breast cancer 
in the lowest SES group in patients diagnosed in the west of patients (1971-1980) from the highest social class the relative 
Scotland in the period 1980- 1987, using an area-based measure risk of dying after correction for age, period of diagnosis, and 
of SES [8]. Even in studies which adjusted for differences in stage was reduced to 0.78 (95% CI (0.68-0.90)) [5]. Women 
stage distribution across SES groups, a statistically significant from the United States (1979-1983) living in areas with at least 
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1. 
2. 
35% working class, experienced a relative risk of mortality of 
1.52 (95% CI (1.2%1.88)), compared with womenlivingin areas 
with less than 35% working class, adjusted for race, age, stage 
and histology [4]. Our results are thus in the same direction as 
those from most studies conducted in other countries. The 
strength of the association seems to be relatively weak, however, 
in The Netherlands, the age-corrected hazard ratio for the lowest 
SES category being 1.18. 
The most important explanatory factor of socioeconomic 
differences in breast cancer survival in our study appeared to be 
stage of disease at diagnosis. In several studies, it was found that 
women from lower SES groups are diagnosed at more advanced 
stages of breast cancer than women from higher SES groups 
[S, 19-221. Such differences in stage distribution may be related 
to the length of delay between the occurrence of the first 
symptoms and the time of diagnosis, which might be shorter in 
more educated and better informed women. In some studies, 
delay was found to be longer for women of lower SES [22-241, 
and a longer delay was found to be related to more advanced 
stages of breast cancer [24-261, which is related to lower survival 
t261. 
In our study, stage was only moderately associated with SES: 
only a distant stage was more common among lower SES women. 
Credit to this moderate association may be good access to 
primary and specialised care in the southeastern Netherlands as 
a result of relatively short distances to a hospital, good supply of 
health services and a health insurance system without major 
financial obstacles: in the study period only 0.4% of the Dutch 
population was not covered by health insurance [27]. 
Less attention has been given to socioeconomic differences in 
treatment as an explanation for survival differences. It could be 
argued that the choice of treatment, given the extent of disease 
at diagnosis, might be related to the SES of breast cancer 
patients, Although we found no differences in treatment accord- 
ing to SES adjusted for stage (results not shown), differences in 
the quality of treatment of breast cancer patients according to 
SES may exist. Such differences cannot be evaluated, however, 
through the rather rough indicator of treatment used in this 
study. In any case, such differences cannot be responsible for 
large differences in survival in The Netherlands. 
Our findings on the influence of stage on socioeconomic 
differences in breast cancer survival indicate that, with regard to 
secondary prevention of breast cancer, special attention should 
be given to women of lower SES. During the study period, a 
breast cancer screening programme at the population level was 
absent, and is now being implemented in The Netherlands. 
Through health education programmes, women from lower SES 
groups should be especially encouraged to participate in such a 
screening programme as well as to practise breast self examin- 
ation. Such programmes, together with keeping up good general 
access to health care facilities for the entire population, may lead 
to a further reduction of socioeconomic differences in breast 
cancer survival in The Netherlands. 
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